is ozempic a tirzepatide or semaglutide vs Mounjaro: Comparing GLP‑1 Injectable Weight‑Loss Meds, vs Tirzepatide, and Real Side Effects Ozempic vs Semaglutide : A

Higher doses are associated with potential side effects such as severe abdominal pain, stomach problems, nausea, vomiting, diarrhea, and constipation

Oral semaglutide (Rybelsus) is not recommended during breastfeeding because it contains SNAC, a substance that helps your body absorb the medicine and may pass into breast milk

As you can see, the average weight loss is 7.59 pounds in the first month, 12.86 pounds over the first two months, 18.23 pounds over the first three months, 23.49 pounds over the first four months, 27.27 pounds over the first five months, 32.83 pounds over the first six months, 38.49 pounds over the first seven months and then 40.92 pounds over the first eight months

After 20 weeks of treatment, improvements in LM and SMM were observed across all groups except those receiving the lowest dose (52.5 mg)

Tirzepatide produces significant fat loss, but it can also lead to muscle loss if nutrition and exercise are not optimized